Indeed, stimulation of Tie2 by recombinant Angpt-1 or the small molecule VE-PTP inhibitor AKB-9778 normalized many of the gene expression changes induced by plasma from patients with COVID-19 (Figure 1 and Supplemental Figure 2). The gene discussed is TEK; the disease is COVID-19.